Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 18 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

33%

6 trials in Phase 3/4

Results Transparency

21%

3 of 14 completed with results

Key Signals

3 with results100% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (4)
P 2 (3)
P 3 (5)
P 4 (1)

Trial Status

Completed14
Recruiting4

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 14 completed trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT07680842Not ApplicableRecruiting

Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy

NCT06399952Recruiting

Baker Gordon Syndrome Natural History Study

NCT06769659Phase 2RecruitingPrimary

A Study Evaluating NPT 2042 Versus Placebo in Subjects Aged 16-75 Years With Genetic Generalized Epilepsy (GGE) and Absence Seizures

NCT07540013Not ApplicableCompletedPrimary

The Effect of Mandala Coloring on the Quality of Life in Epilepsy Patients: A Single Blind Randomized Controlled Study

NCT04959019Not ApplicableCompletedPrimary

Exercise for Memory Rehabilitation in Epilepsy

NCT06960811Completed

Epileptic Psychoses and Their Link With Ictal Emotions and Consciousness

NCT06579573Phase 3RecruitingPrimary

ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures.

NCT05477121CompletedPrimary

Severity: Quantifying the Severity of Generalized Tonic-clonic Seizures (GTCS) With Connected Devices

NCT05241678CompletedPrimary

Evaluation of the 24/7 EEG™ SubQ System in Subjects With Uncontrolled Genetic Generalised Epilepsy Syndrome

NCT05297695Phase 2CompletedPrimary

Helicobacter Pylori Eradication Therapy for Epileptic Children

NCT04248920Not ApplicableCompletedPrimary

Clinic to Community© Program for Adults With Epilepsy Admitted to Emergency Departments

NCT04439656CompletedPrimary

Detecting Absence Seizures Using Eye Tracking

NCT00319501Phase 3Completed

Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures.

NCT00162981Phase 2Completed

Clobazam in Subjects With Lennox-Gastaut Syndrome

NCT00518713Phase 3Completed

Clobazam in Patients With Lennox-Gastaut Syndrome

NCT00266604Phase 4Completed

A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy

NCT00231556Phase 3Completed

A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy

NCT00236886Phase 3Completed

Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients

Showing all 18 trials

Research Network

Activity Timeline